Literature DB >> 28495993

Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?

Shugo Tohyama1, Keiichi Fukuda1.   

Abstract

Entities:  

Keywords:  cardiac myocyte; differentiation; human pluripotent stem cells; metabolism; purification; regeneration

Mesh：

Year:  2017        PMID： 28495993     DOI： 10.1161/CIRCRESAHA.116.310328

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

1.  Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells.

Authors:  Harshal Nemade; Aviseka Acharya; Umesh Chaudhari; Erastus Nembo; Filomain Nguemo; Nicole Riet; Hinrich Abken; Jürgen Hescheler; Symeon Papadopoulos; Agapios Sachinidis
Journal:  Cells       Date:  2020-02-27       Impact factor: 6.600

2.  Injury-induced Cavl-expressing cells at lesion rostral side play major roles in spinal cord regeneration.

Authors:  Chih-Wei Zeng; Yasuhiro Kamei; Shuji Shigenobu; Jin-Chuan Sheu; Huai-Jen Tsai
Journal:  Open Biol       Date:  2021-02-24       Impact factor: 6.411

3.  Single-cell sequencing reveals the potential oncogenic expression atlas of human iPSC-derived cardiomyocytes.

Authors:  Minglin Ou; Min Zhao; Chunhong Li; Donge Tang; Yong Xu; Weier Dai; Weiguo Sui; Yue Zhang; Zhen Xiang; Chune Mo; Hua Lin; Yong Dai
Journal:  Biol Open       Date:  2021-02-15       Impact factor: 2.422

4.  Purification of cardiomyocytes and neurons derived from human pluripotent stem cells by inhibition of de novo fatty acid synthesis.

Authors:  Sho Tanosaki; Tomohiko Akiyama; Sayaka Kanaami; Jun Fujita; Minoru S H Ko; Keiichi Fukuda; Shugo Tohyama
Journal:  STAR Protoc       Date:  2022-04-28

Review 5.  Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.

Authors:  Yuika Morita; Yoshikazu Kishino; Keiichi Fukuda; Shugo Tohyama
Journal:  Cell Prolif       Date:  2022-05-09       Impact factor: 8.755

6.  Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

Authors:  Fanny Loisel; Bastien Provost; François Haddad; Julien Guihaire; Myriam Amsallem; Bojan Vrtovec; Elie Fadel; Georges Uzan; Olaf Mercier
Journal:  Pulm Circ       Date:  2018-02-26       Impact factor: 3.017

Review 7.  The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells.

Authors:  Yusuke Soma; Yuika Morita; Yoshikazu Kishino; Hideaki Kanazawa; Keiichi Fukuda; Shugo Tohyama
Journal:  Front Cardiovasc Med       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.